The active ingredient in Uroxatral is alfuzosin hydrochloride, a type of alpha-blocker. It is also known by its brand name, Uroxatral, and its generic name, alfuzosin hydrochloride. Uroxatral is available in both oral tablet and extended-release oral capsule form.
Uroxatral has several advantages over other treatments for benign prostatic hyperplasia. It is a once-daily medication, so it is easier to remember to take than multiple-times-daily medications. It also has fewer side effects than other treatments, and it can be used in combination with other treatments.
The history of Uroxatral dates back to the early 2000s. In 2001, the U.S. Food and Drug Administration approved Uroxatral as a treatment for benign prostatic hyperplasia. Since then, it has become a popular treatment option for men with this condition.
Uroxatral is a safe and effective treatment for benign prostatic hyperplasia. It can help reduce symptoms and improve quality of life. Talk to your doctor to see if Uroxatral is right for you.